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The long-term clinical success of dental implants is related to their early osseointegration. This paper reviews the diﬀerent steps
of the interactions between biological ﬂuids, cells, tissues, and surfaces of implants. Immediately following implantation,implants
are in contact with proteins and platelets from blood. The diﬀerentiation of mesenchymal stem cells will then condition the
peri-implant tissue healing. Direct bone-to-implant contact is desired for a biomechanical anchoring of implants to bone rather
than ﬁbrous tissue encapsulation. Surfaces properties such as chemistry and roughness play a determinant role in these biological
interactions. Physicochemical features in the nanometer range may ultimately control the adsorption of proteins as well as the
adhesionanddiﬀerentiation ofcells. Nanotechnologiesare increasinglyused forsurface modiﬁcationsofdental implants.Another
approach to enhance osseointegration is the application of thin calcium phosphate (CaP) coatings. Bioactive CaP nanocrystals
deposited on titanium implants are resorbable and stimulate bone apposition and healing. Future nanometer-controlled surfaces
may ultimately direct the nature of peri-implant tissues and improve their clinical success rate.
1.Introduction
Implants are commonly used in dental surgery for restoring
teeth.Oneofthechallengesin implantologyistoachieveand
maintain the osseointegration as well as the epithelial junc-
tion of the gingival with implants. An intimate junction of
the gingival tissue with the neck of dental implants may pre-
vent bacteria colonisations leading to peri-implantitis while
direct bone bonding may ensure a biomechanical anchoring
of the artiﬁcial dental root (Figure 1).
The ﬁrst step of the osseointegration ofimplants is called
primary stability and is related to the mechanical anchorage,
design of implants, and bone structure [1]. This primary
interlock decreases with time at the beneﬁt of the secondary
anchorage, which is characterized by a biological bonding
at the interface between bone tissues and implant surface.
Between the primary mechanical and secondary biological
anchorage, a decrease of implant stability could be observed.
Many studies have attempted to enhance the osseointegra-
tion of implants by various surface modiﬁcations. The aim is
to provide metal implants with surface biological properties
for the adsorption of proteins, the adhesion and differ-
entiation of cells, and tissue integration. These biological
properties are related to chemical composition, wettability,
and roughness of metal implants surfaces. However, the
control of these surface properties at the protein and cell
levels, thus in the nanometre range, remains a challenge for
researchers and dental implants manufacturers.
Nanotechnologies may produce surfaces with controlled
topography and chemistry that would help understanding
biologicalinteractionsanddevelopingnovelimplantsurfaces
with predictable tissue-integrative properties [2, 3]. Various
processing methods derived from the electronic industry
such as lithography, ionic implantation, anodization, and
radio frequency plasma treatments may be applied to the
surfaces of dental implants to produce controlled features at
the nanometer scale. These surfaces may then be screened by
usinghighthroughputbiologicalassays invitro.Forinstance,
speciﬁc proteinadsorption, celladhesion, anddiﬀerentiation
of stem cells should be studied in relation to the surface2 International Journal of Biomaterials
properties. This approach may deﬁne the ideal surface for
a speciﬁc biological response. Following in vitro screening,
nanostructuredsurfaces maythenbetestedinanimal models
to validate hypothesis in a complex in vitro environment.
New coating technologies have also been developed for
applying hydroxyapatite and related calcium phosphates
(CaP), the mineral of bone, onto the surface of implants
(Figure 2). Many studies have demonstrated that these CaP
coatings provided titanium implants with an osteoconduc-
tive surface [4, 5]. Following implantation, the dissolution
of CaP coatings in the peri-implant region increased ionic
strength and saturation of blood leading to the precipita-
tion of biological apatite nanocrystals onto the surface of
implants. This biological apatite layer incorporates proteins
and promotes the adhesion of osteoprogenitor cells that
would produce the extracellular matrix of bone tissue.
Furthermore, it has been also shown that osteoclasts, the
bone resorbing cells, are able to degrade the CaP coatings
through enzymatic ways and created resorption pits on the
coated surface [5]. Finally, the presence of CaP coatings on
metalspromotesan early osseointegration ofimplants with a
direct bonebonding as compared tononcoated surfaces. The
challenge is to produce CaP coatings that would dissolve at
a similar rate than bone apposition in order to get a direct
bone contact on implant surfaces.
This paper reviews the diﬀerent steps of the interac-
tions between biological ﬂuids, cells, tissues, and surfaces
of implants. Recent nanoscale surface modiﬁcations and
calcium phosphate coating technologies of dental implants
are discussed. The sequence of biological events in relation
to surface properties is related. Mechanisms of interaction
with blood, platelets, hematopoietic, and mesenchymal stem
cells on the surface of implants are described. These early
events have shown to condition the adhesion, proliferation,
and diﬀerentiation of cells as well as the osseointegration of
implants. Future implant surfaces may improve the tissue-
integrative properties and long-term clinical success for the
beneﬁts of patients.
2.Nanoscale SurfaceModiﬁcations
Surfaces properties play a determinant role in biological
interactions. In particular, the nanometer-sized roughness
and the chemistry have a key role in the interactions of
surfaces with proteins and cells. These early interactions will
in turn condition the late tissue integration. In this prospect,
diﬀerent methods have been reported for enhancing bone
healing around metal implant [2, 6].
Modifying surface roughness has been shown to enhance
the bone-to-implant contact and improve their clinical
performance [2, 7]. Grit blasting, anodisation, acid etching,
chemical grafting, and ionic implantation were the most
commonly used methods for modifying surface roughness
of metal implants. Combinations of these techniques could
be used such as acid etching after grit-blasting in order to
eliminate the contamination by blasting residues on implant
surfaces. This grit blasting residue may interfere with the
osteointegration of the titanium dental implants [8–10].
It has been shown that grit-blasting with biphasic calcium
phosphate (BCP) ceramic particles gave a high average
surfaceroughnessandparticle-freesurfacesafteracidetching
of titanium implants. Studies conducted both in vitro and
in vivo have shown that BCP grit-blasted surfaces promoted
an early osteoblast diﬀerentiation and bone apposition
as compared to mirror-polished or alumina grit-blasted
titanium [11, 12]. Anodization is a method commonly used
to obtain nanoscale oxides on metals including titanium [13,
14]. By adjusting the anodization condition such as voltage,
time, and shaking, nanoscale properties could be controlled.
Shankar et al. [15] have reported that the diameters of
the nanotubes could be modiﬁed to a range from 20 to
150nm in modifying voltage conditions. On the other hand,
Kang et al. [16]f o u n dt h a tT i O 2 nanotube arrays were
more uniform on electro-polished than machined titanium.
Moreover, TiO2 nanotubesonTiimprovedtheproductionof
alkaline phosphatase (ALP) activity by osteoblastic cells. In
particular, nanotubes with a diameter of100nm upregulated
level of ALP activity as compared to 30–70nm diameter
nanotube surfaces [17]. Since ALP is a marker of osteogenic
diﬀerentiation, these surfaces may demonstrate enhanced
bone tissue integrative properties.
Another approach for improving osseointegration of
dental implants is to apply a CaP coating having osteo-
conductive properties [18–20]. Diﬀerent methods have been
developed to coat metal implants with CaP layers such as
plasma spraying,biomimetic andelectrophoretic deposition.
Nevertheless, plasma-sprayed HA-coated dental implants
have been related to clinical failures due to coating delimita-
tion and heterogeneous dissolution rate of deposited phases.
An electrochemical process which consists of depositing cal-
cium phosphate crystals from supersaturated solutions has
been proposed for coating titanium implants with calcium
phosphate layers [21, 22]. Upon implantation, these CaP
coatings dissolve and release Ca2+ and HPO4
2− increasing
saturation of blood in the peri implant region. This dissolu-
tion ledto theprecipitation ofbiologicalapatite nanocrystals
with the incorporation of various proteins. This biological
apatite layer will promote cell adhesion, diﬀerentiation into
osteoblast, and the synthesis of mineralized collagen, the
extracellularmatrixofbonetissue.Inadditiontodissolution,
osteoclast cells are also able to resorb the CaP coatings and
activate osteoblast cells to produce bone tissue. As a result,
these CaP coatings promote a direct bone-implant contact
without an intervening connective tissue layer leading to a
proper biomechanical ﬁxation of dental implants.
3.InteractionsofSurfaceDentalImplants
withBlood
During surgery, blood vessels are injured and, thus,
dental implant surfaces interact with blood components
(Figure 3). Various plasma proteins get adsorbed on the
material surface within a minute. Platelets from blood
interact also with the implant surface. Plasma proteins
modiﬁed the surface while activated platelets are responsible
of thrombus formation and blood clotting. Subsequently,International Journal of Biomaterials 3
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Figure 1: Tissue integration of dental implant. Note the intimate contact with gingival tissue in the upper part and the desired contact
osteogenesis in the tapered lower part rather than distance osteogenesis.
the migrations of various cell types interact with the surface
through membrane integrin receptors. These early events
occur prior to peri implant tissue healing.
Plasma contains dissolved substances such as glucose,
amino acids, cholesterols, hormones, urea, and various ions
(Figure 4). Most of these components are needed for the
viability of cells and tissues. All of these blood substances
could interact with implant surface thus modifying their
chemical properties like charge or hydrophobicity.
Blood interactions with implants lead to protein adsorp-
tion, which is dependent on the surface properties of the
material and occurs through a complex series of adsorption
and displacement steps known as the Vroman eﬀect [23].
A hydrophilic surface is better for blood coagulation than a
hydrophobic surface. Consequently, dental implants manu-
facturershavedevelopedhighhydrophilicandroughimplant
surfaces which in turn exhibited better osteointegration
than conventional ones [24]. Adsorption of proteins such as
ﬁbronectin, vitronectin on surface of dental implants could
promotecelladhesionbycell-bindingRGDdomain(arg-gly-
asp). This RGD sequence interacts with integrin present on
the cellmembrane [25].Interactions between cellmembrane
integrins and proteins coated onto implant surface play a
key role in adhesion of many cells types. After proteins
absorption, the osteointegration is characterized by platelets
adhesion and ﬁbrin clots formation at the injured blood
vessels site. It has been shown that implants in contact with
platelet-rich plasma (PRP) with a platelet concentration of
approximately 1,000,000 protein/μLh a v eap o s i t i v ee ﬀect
on osteointegration. At lower concentrations of PRP, the
eﬀect was not optimal, while higher concentrations resulted
in a paradoxically inhibitory eﬀect of bone regeneration.
Other studies were not in agreement with this PRP beneﬁcial
eﬀect on the osseointegration of dental implants [26].4 International Journal of Biomaterials
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Figure 2: Scanning electron micrographs and energy dispersive analysis for X-ray of (a) nanostructured titanium surface obtained by
anodizationand(b) nanosizedthincalcium phosphate(CaP)coating ontitanium produced by electrochemical deposition. Note the regular
array of TiO2 nanopores of approximately 100 nm in diameter and the nanosized CaP crystals on titanium surfaces.
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Figure 3: Interactions of surface of dental implants with blood.
Note the numerous proteins, red blood cells, and activated platelets
that lead to blood clotting on implants.
The assessment of bioactivity of surface-treated dental
implants should be tested in vitro using biological ﬂuids
containing blood components [2].
4.InteractionsbetweenSurfacesand
Mesenchymal StemCells
Following blood clotting around dental implants, several
cells interact with surfaces for tissue healing. Mesenchymal
stemcells(MSCs)attractedtotheinjured sitebychemotactic
factors haveadeterminantroleinperiimplanttissuehealing.
4.1. Origin of Mesenchymal Stem Cells. Mesenchymal stem
cells(MSCs)are stemcellsderivedfrom somatictissue which
can be diﬀerentiated into mesenchymal lineages such as
b o n e ,c a r t i l a g e ,f a t ,a n ds k i n .I na d d i t i o n ,M S C sa r ep r e s e n t
in many conjunctive tissues and blood at low concentrations
serving as a sort of internalrepair system. Mesenchymal stem
cellsare distinguished fromothercelltypesbytwoimportant
characteristics. First, they are unspecialized cells able to
renew themselves through cell division, sometimes after long
periods of inactivity. Second, under certain physiologic or
experimental conditions, they can be induced to become
tissue- or organ-speciﬁc cells with special functions. MSCs
have high proliferative and multipotent capacity leading
to diﬀerentiated cells under the guidance of various cues
or niches. MSCs are conventionally deﬁned as adherent,
nonhematopoietic cells expressing markers such as CD13,
CD29, CD44, CD54, CD73, CD90, CD105, and CD166, and
being negative for CD14, CD34, and CD45 [27, 28]. While
originally identiﬁed in the bone marrow [29], MSCs have
been extracted from numerous tissues including adipose
[30, 31], heart [32], dental pulp [33], peripheral blood
[34], and cord blood [35] .O n eo ft h em a j o rp r o p e r t i e so f
MSCs is their ability to diﬀerentiate into various cells like
adipocytes[36],chondrocytes[30],osteoblasts[37],neurons
[38, 39], muscles [39, 40], and hepatocytes [41] in vitro after
treatment with induction agents.
4.2. Migration, Adhesion, and Proliferation. The integra-
tion of implant with neighboring bone and gingival tis-
sue depends on successful crosstalk between old tissue andInternational Journal of Biomaterials 5
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Figure 4: Scheme showing blood composition and components that primary interact with surface of dental implants.
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Figure 5:Schemeoftheadhesion,proliferation,anddiﬀerentiation
of mesenchymal stem cells on nanostructured surfaces. The adhe-
sion of stem cells is characterized by the expression of cell surface
markers (VCAM, ITG, and THY1) while phenotypic markers
( R u n x 2 ,A L P ,O C N ,a n dO P N )a r es p e c i ﬁ ct ot h e i ro s t e o b l a s t i c
diﬀerentiation (OCN: osteocalcin; OPN: osteopontin).
implant surface. The challenge in dental implant research is
the capability of the surface to guide cells colonization and
diﬀerentiation. Cell migration, adhesion, and proliferation
on implant surfaces are a prerequisite to initiate the tissue
regeneration (Figure 5). Authors have shown that some fac-
tors present in tissues and secreted during the inﬂammatory
phase are able to attract MSCs to the injured site [42, 43].
MSCsmigrationandproliferationwerestimulatedinvitroby
many growth factors including PDGF [44, 45], EGF [45, 46],
VEGF [47], TGF-β [44, 48], and BMP-2 and BMP-4 [44, 47].
Thesefactorsare certainlyreleased intheinjured sitesbycells
involvedin tissue healing. Furthermore,plasma clotservesas
storage to ﬁbrin molecules and releases system for a variety
of bioactive factors including growth factors that attract and
diﬀerentiateMSCsintospeciﬁclineages[49–51].Theplatelet
factorsare well knowntostimulate theproliferationofMSCs
[52]. The formation of a clot matrix with a potent chemoat-
tractive factor likePDGF, EGF,or ﬁbrinmay further enhance
MSCs numbers and peri implant tissue healing surface.
Moreover, the plasma clot in contact with implant surface
represents a three-dimensional microporous structure that
allows diﬀusion of regulatory factors [53, 54] and is involved
in the migration, proliferation, and differentiation of MSCs.
After MSC recruitment in the injured site, cells adhere on the
local extracellular matrix as well as on the implant surface
beginning an extensive proliferation in order to build up
new tissue. Again, surface modiﬁcations of implants in the
nanometer range condition the biological responses.
4.3. Diﬀerentiation. In the microenvironment, MSCs are
stimulated by some speciﬁc factors to diﬀerentiate into the
adequatecell line.Underthe inﬂuenceof these factors, MSCs
switch to osteoblastic cells in contact to bone tissue while
they diﬀerentiate into ﬁbroblastic lineage in the gingival
tissue region. These two diﬀerentiation pathways are in con-
currencearounddentalimplants.In somecases,implants are
encapsulated by ﬁbrous tissue due to the proliferation and
diﬀerentiation of MSCs into ﬁbroblastic cells. In response
to cytokine, ﬁbroblasts migrate and generate a capsule of
collagen, the ﬁrst step in generation of gingival tissue or
rejection on contact to bone. This ﬁbrous capsule prevents
bonding between implant surface and juxtaposed bone and
causes a failure of the implant [55]. On the other hand,
both the diﬀerentiation of MSCs into ﬁbroblastic lineage
and the ﬁbroblastic adhesion are desired in the gingival
upper part of dental implants. Fibroblasts adhesion has
been shown to be lower on nanoscale surface compared
to conventional surfaces [56]. Moreover, nanometer size
features have been shown to decrease ﬁbroblast adhesion
and proliferation [57, 58]. The micro- and nanoscale surface
properties of metal implant, including chemistry, roughness,
and wettability, could aﬀect bone formation [59]. Numerous
treatments such as machining, grit-blasting, Ti/HA plasma
spray, chemical etching, and anodization are available to
modify theimplant surface. Research hasspeciﬁcally demon-
strated that nanorough Ti [60] and nanostructured Ti can
enhance osteoblast adhesion and diﬀerentiation compared
to their nanosmooth control [61]. Furthermore, surfaces
with micro- and nanopores have shown to enhance greatly6 International Journal of Biomaterials
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Figure 6: Micrographs showing the osteointegration of bare titanium- (Ti-) and calcium phosphate- (CaP-) coated implants after
implantationin femoralcondyles ofrabbits for4weeks. Note the direct bone appositiononCaP-coated implants(arrows)onboth histology
(basic fuchsin, toluidine blue staining) and back-scattered electron microscopy (BSEM) images.
osseointegration [62, 63]. Surface properties may control the
steps of adhesion, proliferation, and diﬀerentiation of MSCs
and, thus, condition tissue integration.
5.TissueIntegration
Br˚ anemark et al. [64] described the osseointegration as
a direct structural and functional bone to implant contact
underload. Aspreviouslydiscussed, thebiologicaleventsoc-
curring at the tissue-implant interface are inﬂuenced by the
chemistry, topography, and wettability of dental implant
surfaces. The challenge in developing new implant surface
consists in increasing the clinical success rate as well as
decreasing the tissue healing time for immediate loading of
implants, particularly in aesthetic situations [65–67]. One
of the objectives is to develop implant surface having pre-
dictable, controlled, and guided tissue healing. For instance,
surfaces that promote contact osteogenesis rather than
distance osteogenesis would be desired in bony site while
intimate ﬁbrous tissue healing in gingival tissue (Figure 1).
In order to enhance this intimate contact between tissues
and implant, surface treatments at the nanometer scale have
been performed on metal implants and tested in various
animal models. Implant surface with various roughnesses
have been used to increase the total area available for osteo-
apposition. Kubo et al. [65] observed a substantial increase
by 3.1 times in bone-titanium interfacial strength by Ti
nanotube (300nm) at 2 weeks of implantation in femur rats.
These results suggest the establishment of nanostructured
surfaces for improved osteoconductivity. Moreover, Ogawa
et al. [68] haveprepared Ti nanostructure by physical vapour
deposition and tested their osseointegration in femur of rats.
They found an increased surface area by up to 40 % and a
greater strength of osseointegration for the nanostructured
compared to an acid-etched surface. Some authors have
correlated the initial events in bone formation adjacent to
surface with the long-term tissue response to these materials
in humans [69, 70].
By mimicking the chemical composition of natural bone,
hydroxyapatite and CaP coatings on Ti greatly enhance
osteointegration. As shown in Figure 6, a greater direct bone
apposition was observed on CaP-coated than on bare Ti-
coated implants. During the bone healing process, calciumInternational Journal of Biomaterials 7
and phosphate ions are released from the CaP coating in the
peri-implant region and saturate body ﬂuids to precipitate a
biological apatite, which serves as a substrate for osteoblastic
cells producing bone tissue. Several authors have shown the
beneﬁtof using CaP-coated titanium implants for improving
the osteointegration [71, 72]. In particular, Le Guehennec et
al. [20]h a v es t u d i e dt h eo s t e o i n t e g r a t i o no ff o u ri m p l a n t
surfaces in the femoral epiphyses of rabbits after 2 and 8
weeks of healing. In this study, the bone-implant contact
and bone growth inside the chambers were compared for
four diﬀerent implant surfaces and shown that biomimetic
coating method may enhance the bone apposition onto tita-
nium. In order to prevent coating delamination and implant
loosening, the CaP coating should dissolve or degrade under
osteoclastic activity at a similar rate than bone apposition.
The ﬁnal result should be a direct bone-implant coating
without the presence of ﬁbrous tissue. Another advantage
of these CaP coatings is related to their preparation by
biomimetic methods at physiological temperature and pH
from simulated body ﬂuids. CaP crystals have characteristics
thatresemblebonemineral intermsofsize andcomposition.
Furthermore, it is possible to incorporate biologically active
drugs such as antibiotics or growth factors during the
precipitation of CaP coatings on Ti implants [73]. These
molecules could be locally and gradually released in the peri
implant reguion for either preventing bacterial infections or
stimulating bone growth.
6.Conclusion
Many reports have shown that nanometer-controlled sur-
faceshaveagreat eﬀectonearlyeventssuchastheadsorption
of proteins, blood clot formation, and cell behaviours
occurring upon implantation of dental implants. These early
events have an eﬀective impact on the migration, adhesion,
and diﬀerentiation of MSCs. Nanostructured surfaces may
controlthediﬀerentiationpathwaysintospeciﬁclineagesand
ultimately direct the nature of peri-implant tissues. Despite
an active research in dental implants, the ideal surface for
predictive tissue integration remains a challenge.
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